IFNG and neoplasm: When ferroptotic tumor cells release intracellular components, these normally sequestered molecules activate DC maturation and promote CD8+ T cell cross‐priming through PRR‐mediated mechanisms, accompanied by IFN‐γ secretion to initiate adaptive immunity [629, 630, 631].